Medtronic, Inc. Unveils EVARpro(R) Suite of Services to Streamline Clinical Use of Aortic Stent Grafts

MINNEAPOLIS--(BUSINESS WIRE)--Improving the efficiency of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today introduced EVARpro®, a suite of value-added services for physicians who specialize in the minimally invasive treatment of aortic aneurysms and injuries with the company’s stent grafts.

MORE ON THIS TOPIC